期刊文献+

芳香化酶抑制剂用于妇科内分泌治疗的临床效果观察 被引量:6

下载PDF
导出
摘要 目的观察芳香化酶抑制剂用于妇科内分泌治疗的临床效果。方法选取医院妇科收治的内分泌疾病患者116例,随机分为观察组和对照组,每组58例。对照组予米非司酮,观察组采用芳香化酶抑制剂,观察2组临床效果。结果观察组总有效率为94.83%,高于对照组的82.76%,差异有统计学意义(P<0.05)。结论芳香化酶抑制剂用于妇科内分泌治疗临床效果显著,能够促进女性内分泌水平的有效恢复,值得临床推广应用。
作者 王艳
出处 《临床合理用药杂志》 2018年第20期75-76,共2页 Chinese Journal of Clinical Rational Drug Use
  • 相关文献

参考文献7

二级参考文献96

  • 1彭超,周应芳.子宫腺肌症318例诊治分析[J].中国妇产科临床杂志,2001,2(2):72-74. 被引量:45
  • 2沈镇宙,宋三泰,张斌,邵志敏,陆劲松.中国绝经前女性乳腺癌患者辅助治疗后绝经判断标准及芳香化酶临床应用共识(草案修正案)[J].中国癌症杂志,2011,21(5):418-420. 被引量:18
  • 3郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:278
  • 4李惠平,季加孚,侯宽永,贾廷珍,赵红梅,肖宇,王墨培,汪有蕃.芳香化酶抑制剂治疗晚期乳腺癌的临床研究[J].北京大学学报(医学版),2007,39(2):193-196. 被引量:8
  • 5Llombart-Cussac A,Ruiz A,Antón A,et al.Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive,advanced breast cancer:final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial[J].Cancer,2012,118(1):241-247.
  • 6Paridaens RJ,Dirix LY,Beex LV,et al.Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women:the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group[J].J Clin Oncol,2008,26(30):4883-4890.
  • 7Wang T,Yang TT,Yang LJ,et al.First-line chemotherapy versus first-line endocrine therapy in hormone receptor positive HER2 negative patients with metastatic breast cancer in China:Results of the study of breast cancer group of the Chinese Society of Clinical Oncology (CSCO)[J].Ann SABCS,2013,12:10-15.
  • 8Bachelot T,Bourgier C,Cropet C,et al.Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive,human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors:a GINECO study[J].Cancer,2012,30(22):2718-2724.
  • 9Osborne CK,Neven P,Dirix LY,et al.Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor- positive metastatic breast cancer:a randomized phase II study[J].Clin Cancer Res,2011,17(5):1147-1159.
  • 10Munster PN,Thurn KT,Thomas S,et al.A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer[J].Br J Cancer,2011,104(12):1828-1835.

共引文献52

同被引文献30

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部